174 related articles for article (PubMed ID: 28079973)
1. A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells.
Elkhadragy L; Chen M; Miller K; Yang MH; Long W
Mol Oncol; 2017 Feb; 11(2):194-207. PubMed ID: 28079973
[TBL] [Abstract][Full Text] [Related]
2. Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer.
Chou CH; Yang NK; Liu TY; Tai SK; Hsu DS; Chen YW; Chen YJ; Chang CC; Tzeng CH; Yang MH
Cancer Res; 2013 Jan; 73(2):953-66. PubMed ID: 23204235
[TBL] [Abstract][Full Text] [Related]
3. ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers.
Alshammari ES; Aljagthmi AA; Stacy AJ; Bottomley M; Shamma HN; Kadakia MP; Long W
BMC Cancer; 2021 Feb; 21(1):155. PubMed ID: 33579235
[TBL] [Abstract][Full Text] [Related]
4. The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.
Elkhadragy L; Alsaran H; Long W
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516969
[TBL] [Abstract][Full Text] [Related]
5. A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration.
Al-Mahdi R; Babteen N; Thillai K; Holt M; Johansen B; Wetting HL; Seternes OM; Wells CM
Cell Adh Migr; 2015; 9(6):483-94. PubMed ID: 26588708
[TBL] [Abstract][Full Text] [Related]
6. Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells.
Yang WH; Lan HY; Tai SK; Yang MH
Biochem Biophys Res Commun; 2013 Mar; 433(1):24-30. PubMed ID: 23454123
[TBL] [Abstract][Full Text] [Related]
7. L290P/V mutations increase ERK3's cytoplasmic localization and migration/invasion-promoting capability in cancer cells.
Alsaran H; Elkhadragy L; Shakya A; Long W
Sci Rep; 2017 Nov; 7(1):14979. PubMed ID: 29101390
[TBL] [Abstract][Full Text] [Related]
8. The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness.
Chen M; Myers AK; Markey MP; Long W
J Cell Physiol; 2019 Aug; 234(8):13220-13232. PubMed ID: 30569573
[TBL] [Abstract][Full Text] [Related]
9. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
[TBL] [Abstract][Full Text] [Related]
10. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.
Long W; Foulds CE; Qin J; Liu J; Ding C; Lonard DM; Solis LM; Wistuba II; Qin J; Tsai SY; Tsai MJ; O'Malley BW
J Clin Invest; 2012 May; 122(5):1869-80. PubMed ID: 22505454
[TBL] [Abstract][Full Text] [Related]
11. Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.
Elkhadragy L; Alsaran H; Morel M; Long W
J Biol Chem; 2018 Oct; 293(42):16193-16205. PubMed ID: 30166347
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinating Enzyme USP20 Regulates Extracellular Signal-Regulated Kinase 3 Stability and Biological Activity.
Mathien S; Déléris P; Soulez M; Voisin L; Meloche S
Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28167606
[TBL] [Abstract][Full Text] [Related]
13. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
Gergely JE; Dorsey AE; Dimri GP; Dimri M
Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis.
Xie X; Piao L; Cavey GS; Old M; Teknos TN; Mapp AK; Pan Q
Oncogene; 2014 Apr; 33(16):2040-52. PubMed ID: 23708658
[TBL] [Abstract][Full Text] [Related]
15. Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.
Seternes OM; Mikalsen T; Johansen B; Michaelsen E; Armstrong CG; Morrice NA; Turgeon B; Meloche S; Moens U; Keyse SM
EMBO J; 2004 Dec; 23(24):4780-91. PubMed ID: 15577943
[TBL] [Abstract][Full Text] [Related]
16. miR‑653‑5p suppresses the growth and migration of breast cancer cells by targeting MAPK6.
Zhang M; Wang H; Zhang X; Liu F
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495824
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.
Luo H; Yang R; Li C; Tong Y; Fan L; Liu X; Xu C
Tumour Biol; 2017 Jul; 39(7):1010428317718414. PubMed ID: 28720065
[TBL] [Abstract][Full Text] [Related]
18. The atypical MAPK ERK3 controls positive selection of thymocytes.
Sirois J; Daudelin JF; Boulet S; Marquis M; Meloche S; Labrecque N
Immunology; 2015 May; 145(1):161-9. PubMed ID: 25521218
[TBL] [Abstract][Full Text] [Related]
19. A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3.
Hansen CA; Bartek J; Jensen S
Cell Cycle; 2008 Feb; 7(3):325-34. PubMed ID: 18235225
[TBL] [Abstract][Full Text] [Related]
20. Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation.
Coulombe P; Rodier G; Pelletier S; Pellerin J; Meloche S
Mol Cell Biol; 2003 Jul; 23(13):4542-58. PubMed ID: 12808096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
